Amgen Inc.
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to tr…
Drug Manufacturers - General
US, Thousand Oaks [HQ]
Cash Flow Statements
15 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||
| Operating Cash Flow (OCF) | 6,336.00 | 5,787.00 | 5,119.00 | 5,882.00 | 6,291.00 | 8,555.00 | 9,077.00 | 10,354.00 | 11,177.00 | 11,296.00 | 9,150.00 | 10,497.00 | 9,261.00 | 9,721.00 | 8,471.00 | |
| Operating Cash (Net) | 6,336.00 | 5,787.00 | 5,119.00 | 5,882.00 | 6,291.00 | 8,555.00 | 9,077.00 | 10,354.00 | 11,177.00 | 11,296.00 | 9,150.00 | 10,497.00 | 9,261.00 | 9,721.00 | 8,471.00 | |
| Accounts Receivable | -36.00 | -210.00 | -557.00 | 348.00 | -38.00 | 136.00 | -420.00 | -214.00 | -58.00 | -378.00 | -504.00 | -427.00 | -429.00 | -746.00 | -1,015.00 | |
| Accounts Payable | 71.00 | 142.00 | -95.00 | 161.00 | -184.00 | 405.00 | -12.00 | -44.00 | 424.00 | -143.00 | 164.00 | 45.00 | -69.00 | 154.00 | -402.00 | |
|
Working Capital
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Change | 109.00 | -301.00 | 365.00 | -45.00 | -393.00 | 1,121.00 | 714.00 | 1.00 | 7,910.00 | 622.00 | -731.00 | -216.00 | -1,194.00 | -733.00 | -484.00 | |
| Other WC | 208.00 | -386.00 | 1,400.00 | -404.00 | -164.00 | 253.00 | 665.00 | 339.00 | 7,411.00 | 1,146.00 | -325.00 | 381.00 | -531.00 | 601.00 | 442.00 | |
| Investing Activities | ||||||||||||||||
| Used Cash (Net) | -3,202.00 | -4,152.00 | -786.00 | -9,990.00 | -8,469.00 | -5,752.00 | -5,547.00 | -8,658.00 | -4,024.00 | 14,339.00 | 5,709.00 | -5,401.00 | 733.00 | -6,044.00 | -26,204.00 | |
| Capital Expenditure | -530.00 | -580.00 | -567.00 | -689.00 | -693.00 | -1,003.00 | -649.00 | -837.00 | -664.00 | -738.00 | -618.00 | -608.00 | -880.00 | -936.00 | -1,112.00 | |
| Purchases of Investments | -12,418.00 | -14,602.00 | -21,183.00 | -26,241.00 | -21,965.00 | -25,878.00 | -25,977.00 | -28,094.00 | -33,607.00 | -18,741.00 | -9,394.00 | -8,477.00 | -8,900.00 | -2,587.00 | -1.00 | |
| Sale/Maturity of Investment | 9,695.00 | 11,127.00 | 21,620.00 | 19,366.00 | 24,213.00 | 20,896.00 | 21,556.00 | 20,417.00 | 30,414.00 | 33,768.00 | 29,390.00 | 6,978.00 | 13,234.00 | 1,218.00 | 1,673.00 | |
| Property, Plant, Equipment (P&PE) | -530.00 | -580.00 | -567.00 | -689.00 | -693.00 | -1,003.00 | -649.00 | -837.00 | -664.00 | -738.00 | -618.00 | -608.00 | -880.00 | -936.00 | -1,112.00 | |
| Acquisitions (Net) | - - | - - | -701.00 | -2,390.00 | -9,434.00 | -165.00 | -359.00 | -21.00 | -19.00 | 195.00 | -13,617.00 | -3,219.00 | -2,686.00 | -3,727.00 | -26,989.00 | |
| Other Investing Activities | 51.00 | -97.00 | 45.00 | -36.00 | -590.00 | 398.00 | -118.00 | -123.00 | -148.00 | -145.00 | -52.00 | -75.00 | -35.00 | -12.00 | 225.00 | |
| Financing Activities | ||||||||||||||||
| Used Cash (Net) | -2,024.00 | -1,232.00 | -674.00 | -419.00 | -2,726.00 | -2,877.00 | -3,117.00 | -2,599.00 | -6,594.00 | -22,490.00 | -15,767.00 | -4,867.00 | -8,271.00 | -4,037.00 | -21,048.00 | |
| Debt Repayment | -1,000.00 | - - | -3,262.00 | -123.00 | -3,371.00 | -5,605.00 | -2,400.00 | -3,593.00 | -4,405.00 | -1,121.00 | -4,514.00 | -6,450.00 | -795.00 | -6,622.00 | -1,454.00 | |
| Dividends Paid | - - | - - | -500.00 | -1,118.00 | -1,415.00 | -1,851.00 | -2,396.00 | -2,998.00 | -3,365.00 | -3,507.00 | -3,509.00 | -3,755.00 | -4,013.00 | -4,196.00 | -4,556.00 | |
|
Common Stock
|
3,379 | 3,866 | 19,464 | 5,895 | 1,128 | 324 | 1,949 | 3,225 | 7,636 | 17,794 | 7,702 | 12,400 | 4,975 | 6,360 | - - | |
| Issued | 171.00 | 80.00 | 11,149.00 | 1,288.00 | 296.00 | 186.00 | 82.00 | - - | 4,476.00 | - - | - - | 8,914.00 | - - | - - | - - | |
| Repurchased | -3,208.00 | -3,786.00 | -8,315.00 | -4,607.00 | -832.00 | -138.00 | -1,867.00 | -3,225.00 | -3,160.00 | -17,794.00 | -7,702.00 | -3,486.00 | -4,975.00 | -6,360.00 | - - | |
| Other Financing Activities | 3,993.00 | 2,474.00 | 254.00 | 4,979.00 | 8,048.00 | 4,531.00 | 3,464.00 | 31.00 | -140.00 | -68.00 | -42.00 | -90.00 | -78.00 | -103.00 | 27,058.00 | |
| Cash Balances | ||||||||||||||||
| Begin of Period | 1,774.00 | 2,884.00 | 3,287.00 | 6,946.00 | 3,257.00 | 3,805.00 | 3,731.00 | 4,144.00 | 3,241.00 | 3,800.00 | 6,945.00 | 6,037.00 | 6,266.00 | 7,989.00 | 7,629.00 | |
| End of Period | 2,884.00 | 3,287.00 | 6,946.00 | 3,257.00 | 3,805.00 | 3,731.00 | 4,144.00 | 3,241.00 | 3,800.00 | 6,945.00 | 6,037.00 | 6,266.00 | 7,989.00 | 7,629.00 | 10,944.00 | |
| Change | 1,110.00 | 403.00 | 3,659.00 | -3,689.00 | 548.00 | -74.00 | 413.00 | -903.00 | 559.00 | 3,145.00 | -908.00 | 229.00 | 1,723.00 | -360.00 | 3,315.00 | |
| Non-Cash Balances | ||||||||||||||||
| Depreciation and Amortization | 1,049.00 | 1,017.00 | 1,060.00 | 1,088.00 | 1,286.00 | 2,092.00 | 2,108.00 | 2,105.00 | 1,955.00 | 1,946.00 | 2,206.00 | 3,601.00 | 3,398.00 | 3,417.00 | 4,071.00 | |
| Stock Based Compensation | 284.00 | 353.00 | 341.00 | 362.00 | 403.00 | 408.00 | 322.00 | 311.00 | 329.00 | 311.00 | 308.00 | 330.00 | 341.00 | 401.00 | 431.00 | |
| Other | 242.00 | 258.00 | 69.00 | 104.00 | 103.00 | -116.00 | -399.00 | 32.00 | 334.00 | 386.00 | -186.00 | -195.00 | 1,276.00 | 1,282.00 | -991.00 | |
| Highlighted metrics | ||||||||||||||||
| Free Cash Flow (FCF) | 5,806.00 | 5,207.00 | 4,552.00 | 5,193.00 | 5,598.00 | 7,552.00 | 8,428.00 | 9,517.00 | 10,513.00 | 10,558.00 | 8,532.00 | 9,889.00 | 8,381.00 | 8,785.00 | 7,359.00 | |
| Cash Conversion Cycle (CCC) | 339.00 | 271.00 | 344.00 | 283.00 | 296.00 | 164.00 | 177.00 | 210.00 | 184.00 | 209.00 | 248.00 | 211.00 | 222.00 | 268.00 | 445.00 | |
| Invested Capital | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Other Operating Inflows/Outflows
|
||||||||||||||||
| Forex Effect on Cash | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - |